
zzso bone disease is a common problem in patients with advanced cancer causing significant morbidity and poor quality of zzso zzso and less toxic treatments, like zzso can reduce morbidity in such zzso 

The objectives of this study were to determine whether zzso acid was administered in accordance with current recommendations for its prescribing and to produce protocols for improved patient zzso 

The study was a retrospective audit of 39 consecutive patients with zzso bone disease secondary to solid zzso who were treated with zzso zzso The records were zzso to establish the administered dose of zzso acid relative to zzso zzso The standards for zzso acid therapy were defined from best practice zzso 

The zzso diagnosis in patients receiving zzso acid was zzso prostate zzso zzso followed by zzso breast zzso zzso gastrointestinal zzso zzso zzso and zzso cell zzso zzso zzso zzso for therapy were zzso bone disease alone 31 zzso zzso alone zzso zzso zzso bone disease with zzso zzso zzso and prevention of chemotherapy induced bone loss zzso zzso The dose of zzso acid was appropriate to the zzso clearance in zzso zzso inappropriate in zzso zzso and unclear from the notes in zzso zzso 

Majority of patients received zzso acid for the appropriate zzso The dose of zzso acid was appropriate to serum zzso clearance in a majority of zzso Poor documentation of data pertaining to zzso acid treatment is observed which can potentially lead to major errors in zzso We recommend using a standard form to document each episode of therapy with zzso zzso 

